JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 23 No. 2 169-175
© 1982 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Livni, E.
Right arrow Articles by Strauss, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Livni, E.
Right arrow Articles by Strauss, W. H.

Beta-methyl[1-11C]heptadecanoic Acid: A New Myocardial Metabolic Tracer for Positron Emission Tomography

Eli Livni, David R. Elmaleh, Shlomo Levy, Gordon L. Brownell and William H. Strauss

Massachusetts General Hospital, Boston, Massachusetts

Correspondence: For reprints contact: D. R. Elmaleh, PhD, Physics Research Laboratory, Massachusetts General Hospital, Boston, MA 02114.

ABSTRACT

We have tagged heptadecanoic acid with C-11 at the carboxyl group and have inserted a methyl radical in the beta position to inhibit beta oxidation of the fatty acid; we have then explored the tracer's potential as an indicator of myocardial metabolism for use with the positron tomograph. In this preliminary evaluation, biodistribution studies were made in rats and dogs, and imaging of normal and infarcted dogs was performed. At 30 min the tissue distribution studies in rats and dogs showed, respectively, 1.9% and 8.3% uptake in the heart. Sequential images of the canine heart exhibited a remarkable uptake, peaking at 16–18 min and retaining the same level of activity over the one-hour study period. Images of the heart after LAD ligation showed an area of diminished uptake corresponding to the region of infarction. Thus this agent has the basic properties required for potential use in the assessment and quantitation of free fatty-acid metabolism in the heart in a manner similar to the measurement of glucose metabolism in the brain with 2-[18F]fluoro-2-deoxy-D-glucose.




This article has been cited by other articles:


Home page
JNMHome page
T. M. Shoup, D. R. Elmaleh, A. A. Bonab, and A. J. Fischman
Evaluation of trans-9-18F-Fluoro-3,4-Methyleneheptadecanoic Acid as a PET Tracer for Myocardial Fatty Acid Imaging
J. Nucl. Med., February 1, 2005; 46(2): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Y Yonekura, A. Brill, P Som, K Yamamoto, S. Srivastava, J Iwai, D. Elmaleh, E Livni, H. Strauss, M. Goodman, et al.
Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement
Science, March 22, 1985; 227(4693): 1494 - 1496.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1982 by the Society of Nuclear Medicine.